Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06317870

Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty

Led by Centre Hospitalier Universitaire Vaudois · Updated on 2024-08-22

80

Participants Needed

1

Research Sites

137 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of this clinical trial is to compare the analgesic effect of pericapsular nerve block (PENG) with intrathecal morphine in patients scheduled for total hip replacement surgery. The main question to be answered is whether the PENG block is equivalent to intrathecal morphine in reducing postoperative pain. Participants will be randomised into two groups. Patients assigned to the PENG group will receive spinal anaesthesia with local anaesthetic (isobaric bupivacaine) alone and a PENG block. Patients assigned to the intrathecal morphine (ITM) group will receive spinal anaesthesia with a mixture of local anaesthetic (isobaric bupivacaine) and morphine (100 mcg) and a sham PENG block to ensure patient blinding.

CONDITIONS

Official Title

Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male and female patients
  • ASA (American Society of Anaesthesiologists) physical status I to III
  • 18 years of age or older
  • Patients scheduled for elective primary hip arthroplasty
  • Able to give written informed consent independently
Not Eligible

You will not qualify if you...

  • Refusal or inability to give consent
  • Allergy to ropivacaine, paracetamol, ibuprofen, ketorolac, morphine, ondansetron, or dexamethasone
  • Bleeding disorders
  • Neurological deficit on the side to be operated on
  • Current use of opioid medications before surgery
  • Kidney failure with GFR less than 30 ml/min
  • Liver failure
  • Pregnant or breastfeeding women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospital of Lausanne

Lausanne, Canton of Vaud, Switzerland, 1011

Actively Recruiting

Loading map...

Research Team

E

Eric Albrecht, Prof

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here